133 related articles for article (PubMed ID: 10956220)
1. Synthesis and structure-activity relationships of a new set of 2-arylpyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
J Med Chem; 2000 Aug; 43(16):3118-24. PubMed ID: 10956220
[TBL] [Abstract][Full Text] [Related]
2. 1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
J Med Chem; 2000 Mar; 43(6):1158-64. PubMed ID: 10737748
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of a new set of 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
Bioorg Med Chem; 2003 Aug; 11(16):3541-50. PubMed ID: 12878146
[TBL] [Abstract][Full Text] [Related]
4. New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Colotta V; Catarzi D; Varano F; Capelli F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Pedata F; Schiesaro A; Morizzo E; Moro S
J Med Chem; 2007 Aug; 50(17):4061-74. PubMed ID: 17665891
[TBL] [Abstract][Full Text] [Related]
5. 1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.
Catarzi D; Colotta V; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
Farmaco; 2004 Feb; 59(2):71-81. PubMed ID: 14871498
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
[TBL] [Abstract][Full Text] [Related]
7. 2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists.
Catarzi D; Colotta V; Varano F; Calabri FR; Lenzi O; Filacchioni G; Trincavelli L; Martini C; Tralli A; Montopoli C; Moro S
Bioorg Med Chem; 2005 Feb; 13(3):705-15. PubMed ID: 15653338
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
9. New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Varani K; Borea PA
J Med Chem; 2005 Jul; 48(15):5001-8. PubMed ID: 16033279
[TBL] [Abstract][Full Text] [Related]
10. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; IJzerman AP
J Med Chem; 1998 Oct; 41(21):3987-93. PubMed ID: 9767636
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists.
Baraldi PG; Cacciari B; Moro S; Spalluto G; Pastorin G; Da Ros T; Klotz KN; Varani K; Gessi S; Borea PA
J Med Chem; 2002 Feb; 45(4):770-80. PubMed ID: 11831890
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.
Lenzi O; Colotta V; Catarzi D; Varano F; Squarcialupi L; Filacchioni G; Varani K; Vincenzi F; Borea PA; Dal Ben D; Lambertucci C; Cristalli G
Bioorg Med Chem; 2011 Jun; 19(12):3757-68. PubMed ID: 21616671
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.
Karton Y; Jiang JL; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
J Med Chem; 1996 Jun; 39(12):2293-301. PubMed ID: 8691424
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
Jiang J; van Rhee AM; Chang L; Patchornik A; Ji XD; Evans P; Melman N; Jacobson KA
J Med Chem; 1997 Aug; 40(16):2596-608. PubMed ID: 9258367
[TBL] [Abstract][Full Text] [Related]
15. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
[TBL] [Abstract][Full Text] [Related]
16. Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor.
van Muijlwijk-Koezen JE; Timmerman H; van der Goot H; Menge WM; Frijtag Von Drabbe Künzel J; de Groote M; IJzerman AP
J Med Chem; 2000 Jun; 43(11):2227-38. PubMed ID: 10841801
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 4-amino-6-(hetero)arylalkylamino-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent A(2A) adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
Bioorg Med Chem; 2003 Dec; 11(24):5509-18. PubMed ID: 14642595
[TBL] [Abstract][Full Text] [Related]
18. Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen.
Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Moro S; Klotz KN; Leung E; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2000 Dec; 43(25):4768-80. PubMed ID: 11123985
[TBL] [Abstract][Full Text] [Related]
19. A new series of 2-alkoxy(aralkoxy)-[1,2,4]triazolo[1,5-a]quinazolin-5-ones as adenosine receptor antagonists.
Al-Salahi R; Geffken D; Koellner M
Chem Pharm Bull (Tokyo); 2011; 59(6):730-3. PubMed ID: 21628909
[TBL] [Abstract][Full Text] [Related]
20. 4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Lenzi O; Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Varani K; Marighetti F; Morizzo E; Moro S
J Med Chem; 2006 Jun; 49(13):3916-25. PubMed ID: 16789747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]